GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: C4.6,S1-cyclo[N-(3-sulfanylpropanoyl)-D-tryptophyl-L-isoleucyl-L-alloisoleucyl-L-asparaginyl-L-2-aminobutanoyl-N-methyl-L-ornithinol] | FE 200 440 [2] | FE-200440
Compound class:
Peptide
Comment: Barusiban (FE 200440) is an oxytocin receptor antagonist [1-2,5]. It was developed by Ferring Pharmaceuticals as a tocolytic agent, to counteract oxytocin-induced myometrial contractions [4]. Chemically it is a synthetic cyclic hexapeptide containing five unnatural amino acids and only one D-amino acid.
|
|
Classification ![]() |
|
Compound class | Peptide |
International Nonproprietary Names ![]() |
|
INN number | INN |
8252 | barusiban |
Synonyms ![]() |
|
C4.6,S1-cyclo[N-(3-sulfanylpropanoyl)-D-tryptophyl-L-isoleucyl-L-alloisoleucyl-L-asparaginyl-L-2-aminobutanoyl-N-methyl-L-ornithinol] | FE 200 440 [2] | FE-200440 |
Database Links ![]() |
|
CAS Registry No. | 285571-64-4 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL2218898 |
DrugBank Ligand | DB12292 |
GtoPdb PubChem SID | 405560331 |
PubChem CID | 9832431 |
Search Google for chemical match using the InChIKey | UGNGRKKDUVKQDF-IHOMMZCZSA-N |
Search Google for chemicals with the same backbone | UGNGRKKDUVKQDF |
Search PubMed clinical trials | barusiban |
Search PubMed titles | barusiban |
Search PubMed titles/abstracts | barusiban |
UniChem Compound Search for chemical match using the InChIKey | UGNGRKKDUVKQDF-IHOMMZCZSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UGNGRKKDUVKQDF-IHOMMZCZSA-N |